ANTIGEN BINDING PROTEINS

摘要

The present invention relates to methods of treating diseases or disorders affecting the eye or optic nerve characterised by elevated ß-amyloid levels or ß-amyloid deposits, particularly age related macular degeneration and glaucoma type diseases and ß-amyloid dependent cataract formation, with antigen binding proteins that bind ß-amyloid peptide and in particular human ß-amyloid peptide.